[ad_1] More than 6% of all patients presenting for TAVR had active cancer. TAVR patients with active cancer were less likely to present with hypertension, diabetes, obesity, coronary artery disease…
Tag: Interventional Cardiology
TAVR triumphs over surgery: Exploring 4-year data from the Evolut Low Risk trial
[ad_1] Steven Yakubov, MD, director of the MidWest Cardiology Research Foundation at OhioHealth Riverside Methodist Hospital, looked at overall valve performance for this study. This included structural valve deterioration, non-structural…
Edwards gains CE mark approval for new tricuspid valve replacement device
[ad_1] Edwards has been evaluating the safety and effectiveness of the Evoque system for quite some time. In November 2022, the company shared one-year data from the TRISCEND study that…
Haemonetics to acquire medical device company known for its TAVR guidewires for $253M
[ad_1] In addition, Haemonetics believes its commercial and clinical capabilities will increase patient access to OpSens devices and potentially help those devices gain regulatory approvals for new indications. “With the…
Key takeaways from ESC Congress 2023
[ad_1] He said the Hot Line late-breaking session 4 included four studies that will likely have help increase the use of intravascular ultrasound (IVUS) and optical coherence tomography (OCT) in the…
Interventional echocardiography expected to grow thanks to new structural heart procedures
[ad_1] “We are moving to the right side of the heart where we now have transcatheter tricuspid valve repair and replacement (TTVR) devices. Ultimately, if I were to predict, I…
Mitigating risk: How the depth of device implantation impacts LAAO outcomes
[ad_1] Examining data from each procedure, the authors determined that 56% of patients belonged in the proximal implant group and the remaining 44% belonged in the distal implantation group. Patients…
Interventional echocardiographers play a key role in the treatment of structural heart disease
[ad_1] “We are responsible for the pre-procedural screening and detection of the disease process, and obviously the intra-procedural imaging has become very intense. It requires a lot of training and…
New TAVR valve, premounted to save cardiologists time, linked to promising 30-day outcomes
[ad_1] The study’s technical success rate was 100%. Resheathing was required during three procedures and was successful each time with no complications. The mean procedure time was 45.1 minutes. One…